Overview
- Description
Betalin is a biotech company focused on developing cell-based therapies for diabetes, aiming to restore insulin production through pancreatic islet transplantation.
- Website
- Country
- Israel
- Sector
- Health Biotechnology
Engage with Betalin Therapeutics*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.